Search - tctmd.com

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

News Conference News

Compelling Unmet Needs in Treatment of CVD

November 07, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

Advertisement

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

TAVR Suitable Even in Patients with Impaired LVEF

Baseline Anemia Raises Risk for Stent Thrombosis After DES

Study Looks at Long-term Mortality Predictors in TAVR Patients

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

SCAI Publishes Cath Lab Best Practices

Experts Give Their Picks for Most Important Developments of 2011

Hospital Readmission After PCI ‘High’

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Renal Denervation Bonus: Improving LV Function

Registry Study: One-Year Outcomes Similar for TAVR, Surgery

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Women Benefit From TAVR as Much as Men, Maybe More

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Compelling Unmet Needs in Treatment of CVD

Medtronic Starts Landmark Study of Hypertension Treatment

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content